|
|
|
Insider
Information: |
Robb Gary Charles |
Relationship: |
|
City: |
Menlo Park |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
20,203 |
|
Indirect Shares
|
25,100 |
|
|
Direct
Value |
$609,525 |
|
|
Indirect Value
|
$757,267 |
|
|
Total
Shares |
45,303 |
|
|
Total
Value |
$1,366,792 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
18
|
Stock
price went up :
|
0
|
12
|
Stock
price went down : |
0
|
6
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
61.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Corcept Therapeutics Inc |
CORT |
|
2024-05-28 |
20,203 |
2024-05-28 |
25,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2023-09-14 |
4 |
D |
$33.80 |
$270,265 |
D/D |
(7,996) |
26,996 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2023-09-19 |
4 |
S |
$32.74 |
$163,677 |
D/D |
(5,000) |
21,996 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2024-05-28 |
4 |
AS |
$30.39 |
$334,294 |
D/D |
(11,000) |
20,203 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
|
2021-02-11 |
4 |
S |
$29.78 |
$101,249 |
D/D |
(3,400) |
197,738 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
|
2021-02-12 |
4 |
S |
$28.22 |
$3,163,899 |
D/D |
(112,100) |
85,638 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
|
2021-01-22 |
4 |
D |
$28.06 |
$7,260,216 |
D/D |
(258,739) |
201,138 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2023-12-06 |
4 |
S |
$27.01 |
$167,786 |
D/D |
(6,212) |
21,390 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-11-18 |
4 |
S |
$26.43 |
$354,188 |
D/D |
(13,401) |
26,143 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2023-12-05 |
4 |
S |
$26.27 |
$36,277 |
D/D |
(1,381) |
27,602 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2023-12-04 |
4 |
D |
$26.26 |
$230,773 |
D/D |
(8,788) |
28,983 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-08-30 |
4 |
D |
$26.14 |
$2,455,121 |
D/D |
(93,922) |
97,524 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-09-07 |
4 |
S |
$26.06 |
$1,303,000 |
D/D |
(50,000) |
49,544 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-11-17 |
4 |
S |
$26.06 |
$260,600 |
D/D |
(10,000) |
39,544 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-11-22 |
4 |
S |
$26.03 |
$125,308 |
D/D |
(4,814) |
21,329 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-11-23 |
4 |
S |
$26.03 |
$4,842 |
D/D |
(186) |
21,143 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-07-06 |
4 |
AS |
$26.00 |
$1,170,000 |
D/D |
(45,000) |
24,123 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-03-17 |
4 |
AS |
$24.68 |
$185,374 |
D/D |
(7,512) |
76,434 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-03-18 |
4 |
AS |
$24.67 |
$123,054 |
D/D |
(4,988) |
71,446 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2023-05-05 |
4 |
D |
$24.07 |
$1,458,305 |
D/D |
(60,586) |
63,997 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2023-05-10 |
4 |
S |
$24.07 |
$336,980 |
D/D |
(14,000) |
19,997 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2024-03-01 |
4 |
D |
$24.06 |
$15,783 |
D/D |
(656) |
18,809 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
|
2021-04-23 |
4 |
AS |
$24.02 |
$240,219 |
D/D |
(10,000) |
75,638 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2023-05-09 |
4 |
S |
$23.87 |
$716,100 |
D/D |
(30,000) |
33,997 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2021-08-30 |
4 |
D |
$21.53 |
$1,742,595 |
D/D |
(80,938) |
142,848 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2021-09-13 |
4 |
S |
$20.89 |
$132,445 |
D/D |
(6,341) |
136,507 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|